PolySia Nanoparticle Modulates Macrophages Response Through Siglec Agonism as Mechanism of Action for Macular Degeneration Treatment
Time: 1:30 pm
day: Conference Day 1
Details:
- Revolutionizing the latest advancement in genomics and proteomics to improve understanding of disease pathogenesis, beyond simple genetic mutations
- Uncovering the relationships between genomic alterations and disease phenotypes, and gaining insights into how inflammation can lead to different disease manifestations
- Discussing emerging methodologies and technologies advancing the understanding of complex molecular interactions underlying disease progression and paving the way for more effective interventions and personalized medicine approaches
